143 related articles for article (PubMed ID: 29718751)
1. Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials.
Oldenburg CE; Venkatesh Prajna N; Krishnan T; Rajaraman R; Srinivasan M; Ray KJ; O'Brien KS; Glymour MM; Porco TC; Acharya NR; Rose-Nussbaumer J; Lietman TM
Ophthalmic Epidemiol; 2018 Aug; 25(4):315-322. PubMed ID: 29718751
[TBL] [Abstract][Full Text] [Related]
2. Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Devi L; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Jun; 135(6):520-525. PubMed ID: 28426856
[TBL] [Abstract][Full Text] [Related]
3. Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Srinivasan M; Das M; Ray KJ; O'Brien KS; Oldenburg CE; McLeod SD; Zegans ME; Porco TC; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Dec; 134(12):1365-1372. PubMed ID: 27787540
[TBL] [Abstract][Full Text] [Related]
4. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole.
Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Prajna L; Srinivasan M; Raghavan A; Oldenburg CE; Ray KJ; Zegans ME; McLeod SD; Porco TC; Acharya NR; Lietman TM;
JAMA Ophthalmol; 2013 Apr; 131(4):422-9. PubMed ID: 23710492
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole.
Rose-Nussbaumer J; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; Porco TC; McLeod SD; Acharya NR; Keenan JD; Lietman TM;
Br J Ophthalmol; 2016 Jul; 100(7):929-932. PubMed ID: 26531051
[TBL] [Abstract][Full Text] [Related]
6. Comparison of natamycin and voriconazole for the treatment of fungal keratitis.
Prajna NV; Mascarenhas J; Krishnan T; Reddy PR; Prajna L; Srinivasan M; Vaitilingam CM; Hong KC; Lee SM; McLeod SD; Zegans ME; Porco TC; Lietman TM; Acharya NR
Arch Ophthalmol; 2010 Jun; 128(6):672-8. PubMed ID: 20547942
[TBL] [Abstract][Full Text] [Related]
7. Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial.
Rose-Nussbaumer J; Prajna NV; Krishnan KT; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; Oldenburg CE; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Lietman TM; Acharya NR; Keenan JD;
JAMA Ophthalmol; 2015 Jun; 133(6):642-6. PubMed ID: 25764482
[TBL] [Abstract][Full Text] [Related]
8. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
Arora R; Gupta D; Goyal J; Kaur R
Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
[TBL] [Abstract][Full Text] [Related]
9. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
10. Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial.
Sharma S; Das S; Virdi A; Fernandes M; Sahu SK; Kumar Koday N; Ali MH; Garg P; Motukupally SR
Br J Ophthalmol; 2015 Sep; 99(9):1190-5. PubMed ID: 25740805
[TBL] [Abstract][Full Text] [Related]
11. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I.
Sun CQ; Prajna NV; Krishnan T; Mascarenhas J; Rajaraman R; Srinivasan M; Raghavan A; O'Brien KS; Ray KJ; McLeod SD; Porco TC; Acharya NR; Lietman TM
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4167-73. PubMed ID: 23702779
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo.
Cho J; Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Lin YB; Ray KJ; Lietman TM; Rose-Nussbaumer J;
Am J Ophthalmol; 2018 Aug; 192():142-145. PubMed ID: 29758184
[TBL] [Abstract][Full Text] [Related]
13. Mycotic Antimicrobial Localized Injection: A Randomized Clinical Trial Evaluating Intrastromal Injection of Voriconazole.
Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Austin A; Pickel J; Porco T; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2019 Aug; 126(8):1084-1089. PubMed ID: 30904540
[TBL] [Abstract][Full Text] [Related]
14. Topical Chlorhexidine 0.2% versus Topical Natamycin 5% for the Treatment of Fungal Keratitis in Nepal: A Randomized Controlled Noninferiority Trial.
Hoffman JJ; Yadav R; Sanyam SD; Chaudhary P; Roshan A; Singh SK; Singh SK; Mishra SK; Arunga S; Hu VH; Macleod D; Leck A; Burton MJ
Ophthalmology; 2022 May; 129(5):530-541. PubMed ID: 34896126
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.
Sharma N; Chacko J; Velpandian T; Titiyal JS; Sinha R; Satpathy G; Tandon R; Vajpayee RB
Ophthalmology; 2013 Apr; 120(4):677-81. PubMed ID: 23246119
[TBL] [Abstract][Full Text] [Related]
16. Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II.
Prajna NV; Krishnan T; Rajaraman R; Patel S; Shah R; Srinivasan M; Das M; Ray KJ; Oldenburg CE; McLeod SD; Zegans ME; Acharya NR; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2017 Sep; 135(9):987-991. PubMed ID: 28817744
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Value of Persistent Culture Positivity in Fungal Keratitis in the Mycotic Antimicrobial Localized Injection Trial.
Pickel J; Narayana S; Krishnan T; Ramakrishnan S; Samantaray PP; Porco TC; Redd T; Lietman TM; Rose-Nussbaumer J
Am J Ophthalmol; 2020 Jul; 215():1-7. PubMed ID: 32171765
[TBL] [Abstract][Full Text] [Related]
18. Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial.
Prajna NV; Lalitha P; Rajaraman R; Krishnan T; Raghavan A; Srinivasan M; O'Brien KS; Zegans M; McLeod SD; Acharya NR; Keenan JD; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2016 Jun; 134(6):693-6. PubMed ID: 27054515
[TBL] [Abstract][Full Text] [Related]
19. Update on the Management of Infectious Keratitis.
Austin A; Lietman T; Rose-Nussbaumer J
Ophthalmology; 2017 Nov; 124(11):1678-1689. PubMed ID: 28942073
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Oral Voriconazole Versus Oral Ketoconazole as an Adjunct to Topical Natamycin in Severe Fungal Keratitis: A Randomized Controlled Trial.
Sharma N; Singhal D; Maharana PK; Sinha R; Agarwal T; Upadhyay AD; Velpandian T; Satpathy G; Titiyal JS
Cornea; 2017 Dec; 36(12):1521-1527. PubMed ID: 28902012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
